Furthermore, we also investigated whether PD-1 expression has the potential to serve as a prognostic or a predictive biomarker for the recurrence and mortality of cervical cancer patients since no previous research on PD-1 expression status on T cells and its correlation with survival was reported in cervical cancer studies. This evidence concerns the gene PDCD1 and cervical carcinoma.